Clinical trials of TB vaccines: Harmonization and cooperation

Tuberculosis

Volumn 92, Issue SUPPL.1, 2012, Pages

  Mahomed, Hassan ^a   Fourie, P Bernard ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Clinical endpoints; Clinical trials; Routes of administration; Tuberculosis; Vaccines

Indexed keywords

BCG VACCINE;

DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; INFECTION RISK; MIXED INFECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TUBERCULOSIS;

EID: 84858724066     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/S1472-9792(12)70008-2     Document Type: Article

References (19)

1. LJ Abu-Raddad, L Sabatelli, JT Achterberg, JD Sugimoto, IM Longini Jr, C Dye et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics Proc Natl Acad Sci U S A 106 2009 13980 13985
2. D Young, C Dye The development and impact of tuberculosis vaccines Cell 124 2006 683 687 (Pubitemid 43261442)
3. Stop TB Working Group on TB vaccines Tuberculosis Vaccine Candidates - 2010 http://www.stoptb.org/wg/new-vaccines/assets/documents/ TB$20Vaccine$20Pipeline$2010$20-$2003$ 2021$2011.pdf accessed on 18 November 2011.
4. T Hawkridge, H Mahomed Prospects for a new, safer and more effective TB vaccine Paediatr Respir Rev 12 2011 46 51
5. R Rowland, H McShane Tuberculosis vaccines in clinical trials Expert Rev. Vaccines 10 2011 645 658
6. SP Tripathy Fifteen year follow-up of the Indian BCG prevention trial Bull. Int Union Tubercle Lung Dis 62 1987 69 72 (Pubitemid 18035966)
7. L Barker, L Hessel, B Walker Rational approach to selection and clinical development of TB vaccine candidates Tuberculosis 2012 this issue.
8. PE Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
9. LC Rodrigues, VK Diwan, JG Wheeler Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis Int J Epidemiol 22 1993 1154 1158 (Pubitemid 24025695)
10. I Sutherland, E Svandova, S Radhakrishna Alternative models for the development of tuberculosis disease following infection with tubercle bacilli Bull Int Union Tuberc 51 1976 171 179
11. H Mulenga, S Moyo, L Workman, T Hawkridge, S Verver, M Tameris et al. Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trials Vaccine 29 2011 4316 4321
12. M Hatherill, S Verver, H Mahomed Consensus Statement on Diagnostic EndPoints for Infant Tuberculosis Vaccine Trials Clin Infect Dis 2011; Dec 5 [Epub ahead of print]
13. KP Asante, S Abdulla, S Agnandji, J Lyimo, J Vekemans, S Soulanoudjingar et al. Safety and efficacy of the RTS, S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial Lancet Infect Dis 11 2011 741 749
14. JJ Aponte, P Aide, M Renom, I Mandomando, Q Bassat, J Sacarlal et al. Safety of the RTSS/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial Lancet 370 2007 1543 1551 (Pubitemid 350018877)
15. PB Fourie, WA Germishuizen, YL Wong, DA Edwards Spray drying TB vaccines for pulmonary administration Expert Opin Biol Ther 8 2008 857 863 (Pubitemid 352006998)
16. White AD, et al. An evaluation of the mucosal immunogenicity of BCG prime/mucosal boost vaccine regimens in macaques. Poster presentation, Second Global Forum on TB Vaccines. Tallinn, Estonia, 2010.
17. Aldwell W. An oral delivery system for targeting TB vaccines to the mucosal immune system. In: Second Global Forum on TB Vaccines. Tallinn, Estonia, 2010.
18. L Garcia-Contreras, YL Wong, P Muttil, D Padilla, J Sadoff, J Derousse et al. Immunization by a bacterial aerosol Proc Natl Acad Sci U S A 105 2008 4656 4660 (Pubitemid 351753802)
19. The Gambia Hepatitis Study Group The Gambia Hepatitis Intervention Study Cancer Res 47 1987 5782 5787